Evaluating the Safety and Antiviral Activity of Monoclonal Antibody VRC01 in Infants With HIV Receiving Combination Antiretroviral Therapy
Clinical trial NCT03208231 · COMPLETED
Trial details
- NCT number
- NCT03208231
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-08-06
- Primary completion
- 2020-06-16
- Enrollment
- 61
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.